Eris Lifesciences Limited Operating Income Margin for the year ending March 31, 2025: 57.66%

Eris Lifesciences Limited Operating Income Margin is 57.66% for the year ending March 31, 2025, a 131.82% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Eris Lifesciences Limited Operating Income Margin for the year ending March 31, 2024 was 24.87%, a -1.97% change year over year.
  • Eris Lifesciences Limited Operating Income Margin for the year ending March 31, 2023 was 25.37%, a -20.73% change year over year.
  • Eris Lifesciences Limited Operating Income Margin for the year ending March 31, 2022 was 32.01%, a -1.51% change year over year.
  • Eris Lifesciences Limited Operating Income Margin for the year ending March 31, 2021 was 32.50%, a 6.85% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin